The validated VAMP3 is generally regarded as a kind of biomarker of cell aging associated with multiple kinds of tumors, such as pancreatic cancer and breast cancer [32], and can reduce cell invasiveness [33]. This evidence concerns the gene VAMP3 and breast carcinoma.